Titomic (ASX:TTT) signed a teaming agreement with REPKON USA, which replaces the previously agreed Turkish joint venture agreement and establishes a US framework to leverage Titomic's kinetic fusion cold spray technology in REPKON USA's existing product lines, according to a Tuesday Australian bourse filing/
Under the agreement, Titomic and the advanced metal and defense manufacturer will engage in joint research, development, and testing of kinetic fusion cold spray applications in cannon barrels, gun barrels, and warheads. Titomic will also work with REPKON to leverage the technology for the repair of assets in the field.
Titomic will partner on coatings of the REPKON barrels to provide increased performance moving forward.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.